Please check your internet connection and try again.
# Piperacillin-Tazobactam
## Overview
Piperacillin-tazobactam is a combination antibiotic consisting of a broad-spectrum penicillin-class antibacterial agent (piperacillin) and a beta-lactamase inhibitor (tazobactam). It is bactericidal.
## Primary Indications
* Complicated intra-abdominal infections
* Complicated skin and skin structure infections (including diabetic foot infections)
* Community-acquired pneumonia
* Nosocomial pneumonia
* Febrile neutropenia (empiric treatment)
## Adult Dosing
Standard dosing is 3.375 grams every 6 hours or 4.5 grams every 6 or 8 hours. Dosing frequency and duration depend on the indication, severity of infection, and patient response. Dosing is typically based on the piperacillin component.
## Pediatric Dosing
For patients 2 months and older:
* **Complicated intra-abdominal infections:** 100 mg piperacillin/12.5 mg tazobactam per kg per dose every 8 hours.
* **Febrile neutropenia:** 100 mg piperacillin/12.5 mg tazobactam per kg per dose every 8 hours.
* Maximum dose: 4.5 grams per dose.
* Consult specific institutional guidelines or literature for more detailed pediatric dosing and renal/hepatic adjustments.
## Dose Adjustments
* **Renal Impairment (CrCl < 20 mL/min):** Reduce dose frequency. For standard dosing regimens, administer every 8 or 12 hours depending on the specific regimen. For doses exceeding 2 grams of piperacillin, standard doses should be reduced by one-third.
* **Hepatic Impairment:** No specific dose adjustment is generally recommended, but caution is advised.
## Contraindications
* Hypersensitivity to piperacillin, tazobactam, other penicillins, or any component of the formulation.
* History of severe immediate allergic reaction to beta-lactams.
## Adverse Effects
* Diarrhea, nausea, vomiting, rash, pruritus, headache, insomnia.
* **Serious:** Clostridioides difficile-associated diarrhea, hypersensitivity reactions (including anaphylaxis), seizures, interstitial nephritis, hematologic changes (neutropenia, thrombocytopenia).
## Key Drug Interactions
* **Probenecid:** May increase and prolong piperacillin-tazobactam serum concentrations.
* **Neuromuscular blocking agents:** May prolong neuromuscular blockade.
* **Warfarin:** May decrease warfarin effect. Monitor INR closely.
* **Methotrexate:** May decrease methotrexate serum levels.
## Monitoring
* Renal function (baseline and periodically).
* Liver function tests.
* Complete blood count (especially in prolonged therapy).
* Signs and symptoms of infection and hypersensitivity.
* Electrolytes.
## Clinical Pearls
* Piperacillin-tazobactam is a combination product; dosing is based on the total drug content (e.g., 3.375 g = 3 g piperacillin + 0.375 g tazobactam).
* Administer by slow intravenous infusion over at least 30 minutes to reduce the risk of infusion-related reactions.
* Reconstituted solutions should be used within 24 hours when refrigerated or within 12 hours at room temperature.
* Potential for cross-reactivity in patients with penicillin allergy; exercise caution.
* The development of resistance is possible; use appropriately.
***
*This information is for educational purposes and does not substitute for professional medical advice. Always consult the current prescribing information and institutional protocols before making any treatment decisions.*